Shannon Kelley
Vermogen: 5 M $ op 31-07-2026
Vermogen: 5 M $ op 31-07-2026
Shannon Kelley currently works at Madrigal Pharmaceuticals, Inc., as Secretary, Chief Legal Counsel & Executive VP from 2024.
Ms. Kelley also formerly worked at Genzyme Corp., as Chief Compliance Officer-North America.
Ms. Kelley received her graduate degree from American University Washington College of Law and undergraduate degree from Edmund A. Walsh School of Foreign Service.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 17-08-2026 | 11.474 ( 0,05% ) | 5 M $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| MADRIGAL PHARMACEUTICALS, INC. | Algemeen Adviseur | 05-08-2024 |
| Bedrijven | Functie | Einde |
|---|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Compliance Officer | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
Genzyme Corp.
Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
Edmund A. Walsh School of Foreign Service
Edmund A. Walsh School of Foreign Service Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
American University Washington College of Law
American University Washington College of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops small-molecule drugs for cardiovascular, metabolic and liver diseases | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau